SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is seeing significant investor attention centered on the imminent 80th event trigger for the REGAL Phase 3 trial, which stakeholders view as a critical milestone for validating its GPS immunotherapy. The community is heavily focused on the potential for a transformative valuation re-rating, with discussions highlighting strong institutional accumulation and management's commentary on the long-term survival of trial participants.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors react to a deal for 200 aircraft from China while simultaneously digesting news of the company's CEO joining a high-profile U.S. business delegation in Beijing. Community discussion is heavily divided between frustrated shareholders focusing on recent price volatility and longer-term bulls who believe the backlog of orders and the potential for a larger deal make the current dip a buying opportunity.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is at the center of intense market debate as investors brace for the upcoming earnings report, with sentiment split between those expecting a massive beat that ignites an AI rally and bears anticipating a classic sell-the-news event. The community is heavily focused on data center demand, Blackwell shipment updates, and whether the stock's recent volatility is a tactical shakeout by institutions or a sign of an impending correction.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant investor attention as positive clinical data from its pancreatic cancer trials and upcoming ASCO presentation fuel momentum toward recent price highs. The community is actively discussing the stock's growth potential and ongoing de-risking milestones, with many pointing to recent analyst price target increases as a sign of building institutional confidence.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA Group is currently a major focus for investors as they head into earnings, with community sentiment split between those impressed by the brand's rapid store expansion and those skeptical of its high valuation. The stock is seeing significant activity as traders debate whether the company can maintain its momentum against a challenging macro backdrop, fueling active discussions on whether to hold through the volatility or play the earnings move.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing significant selling pressure as investors react to ongoing financial losses, internal management concerns, and a highly polarized community debate regarding the company's business viability. The stock remains a focal point for intense discourse, with participants actively discussing the correlation between the company's performance, the broader political environment, and the challenges of sustaining its operations.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is capturing significant attention as investors anticipate a major shift toward high-performance computing and AI infrastructure, with the community actively speculating on the timing of a potential hyperscaler partnership. Despite ongoing debates regarding execution and the company's fiscal performance, high short interest has fueled significant discussion around the potential for a substantial short squeeze in the near term.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is facing sustained downward pressure as investors express frustration over leadership turnover and a weaker earnings outlook, with many on social media debating whether the current oversold levels represent a buying opportunity or a signal of further declines. The community remains heavily divided between those who believe in the brand's long-term subscription-based model and those concerned by the stock's persistent lack of upward momentum.

Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization, and secure operation of electronics systems to communications, networking, and electronics industries. It operates through the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The CSG segment serves customers spanning the global commercial communications and aerospace, defense, and government end markets. The EISG segment offers test and measurement solutions across electronic industrial end markets, focusing on applications in the automotive, and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.

Keysight Technologies Inc

Keysight Technologies is trending as investors weigh strong AI and data center demand against a cautious revenue outlook heading into its upcoming earnings release. The community remains focused on whether the companys pivot to high-speed networking and software-centric solutions can sustain momentum amidst a broader semiconductor industry reset.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is currently the center of intense debate among retail traders, with many pointing to potential market manipulation and aggressive short selling as reasons for the stock's recent decline toward 52-week lows. While some investors remain optimistic about a long-term turnaround driven by cost-cutting initiatives and strong consumer demand, others are wary of ongoing geopolitical headwinds and the impact of lower guidance on the stock's near-term performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TNYA Series B warrants (.70) expire on June 30. That&#39;s another 24.5m in the bank for Tenaya. Just sit tight and ignore the trolls. Hedge funds are trying to shake you out for liquidity

Rolfthewild

Jay Rau

James E Knaus

Dharma-Zen

$TNYA And soon when it is $2.50+ the $1.50  warrants will be converted and it will be another cool $75 million in TNYA’s company coffers!

StockTwits for iOS

StockTwits Web

Tenaya Therapeutics Inc

 Series B warrants (.70) expire on June 30. That's another 24.5m in the bank for Tenaya. Just sit tight and ignore the trolls. Hedge funds are trying to shake you out for liquidity